CME Supplements

A Special Supplement on Women’s Health

This supplement is sponsored by Primary Care Education Consortium and Primary Care Metabolic Group. It is supported by educational grants from Allergan, Inc. and funding from AstraZeneca; Duchesnay USA; Horizon Pharma, Inc.; and Novo Nordisk, Inc.

 

While better appreciated than 2 decades ago, gender-related differences remain an important issue in clinical practice. This supplement includes 8 articles that focus on the needs and considerations in providing care to women. Four articles focus on cardiometabolic diseases: acute coronary syndrome, coronary heart disease, obesity, and diabetes mellitus. Additional topics include the early management of rheumatoid arthritis and the pharmacologic management of nausea and vomiting of pregnancy.

The last 2 articles each offer the opportunity to earn 1 free CME credit: The Pharmacologic Management of Idiopathic Overactive Bladder in Primary Care and Chronic Migraine in Women. Credit is awarded for successful completion of the quizzes at the links below; these links may also be found in the Women’s Health supplement on the first page of each article.

The Pharmacologic Management of Idiopathic Overactive Bladder in Primary Care www.pceconsortium.org/oab

Chronic Migraine in Women www.pceconsortium.org/migraine

Click here to view the supplement

Recommended Reading

Reducing hospital readmissions through primary care practice transformation
MDedge Family Medicine
Insulin for type 2 diabetes: How and when to get started
MDedge Family Medicine
Tinnitus: Steps to take, drugs to avoid
MDedge Family Medicine
How best to treat UTIs in women who breastfeed?
MDedge Family Medicine
Which drugs are most effective for recurrent herpes labialis?
MDedge Family Medicine
When you suspect ACS, which serologic marker is best?
MDedge Family Medicine
New CVD guidelines put focus in the right place
MDedge Family Medicine
The new cardiovascular disease prevention guidelines: What you need to know
MDedge Family Medicine
Whither IPAB? Cost-cutting board is idle, but not gone
MDedge Family Medicine
FDA investigating testosterone’s cardiovascular risks
MDedge Family Medicine